PL356819A1 - Białka zawierające konserwowane obszary powierzchniowego antygenu NhhA z Neisseria meningitidis - Google Patents
Białka zawierające konserwowane obszary powierzchniowego antygenu NhhA z Neisseria meningitidisInfo
- Publication number
- PL356819A1 PL356819A1 PL01356819A PL35681901A PL356819A1 PL 356819 A1 PL356819 A1 PL 356819A1 PL 01356819 A PL01356819 A PL 01356819A PL 35681901 A PL35681901 A PL 35681901A PL 356819 A1 PL356819 A1 PL 356819A1
- Authority
- PL
- Poland
- Prior art keywords
- nhha
- proteins
- surface antigen
- neisseria meningitidis
- conserved regions
- Prior art date
Links
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17791700P | 2000-01-25 | 2000-01-25 | |
PCT/AU2001/000069 WO2001055182A1 (en) | 2000-01-25 | 2001-01-25 | PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
Publications (2)
Publication Number | Publication Date |
---|---|
PL356819A1 true PL356819A1 (pl) | 2004-07-12 |
PL216780B1 PL216780B1 (pl) | 2014-05-30 |
Family
ID=22650445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL356819A PL216780B1 (pl) | 2000-01-25 | 2001-01-25 | Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego |
Country Status (18)
Country | Link |
---|---|
US (4) | US7947291B2 (pl) |
EP (2) | EP1252182B1 (pl) |
JP (3) | JP2003523208A (pl) |
KR (1) | KR100698561B1 (pl) |
CN (2) | CN102417537A (pl) |
AU (1) | AU2818101A (pl) |
BR (1) | BR0107857A (pl) |
CA (1) | CA2398139A1 (pl) |
CZ (1) | CZ304379B6 (pl) |
ES (1) | ES2389719T3 (pl) |
HU (1) | HUP0300696A3 (pl) |
IL (2) | IL150822A0 (pl) |
MX (1) | MXPA02007184A (pl) |
NO (1) | NO332229B1 (pl) |
NZ (1) | NZ520445A (pl) |
PL (1) | PL216780B1 (pl) |
WO (1) | WO2001055182A1 (pl) |
ZA (1) | ZA200206153B (pl) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG152917A1 (en) * | 1998-01-14 | 2009-06-29 | Chiron Srl | Neisseria meningitidis antigens |
EP2261347A3 (en) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
NZ581940A (en) * | 1999-04-30 | 2011-07-29 | Novartis Vaccines & Diagnostic | Conserved neisserial antigens |
EP1179072A2 (en) * | 1999-05-19 | 2002-02-13 | Chiron S.P.A. | Combination neisserial compositions |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
NZ520445A (en) * | 2000-01-25 | 2004-02-27 | Univ Queensland | Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA |
PT1947187E (pt) | 2000-02-28 | 2011-07-04 | Novartis Vaccines & Diagnostic | Expressões híbridas de proteínas de neisseria |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
GB0220199D0 (en) * | 2002-08-30 | 2002-10-09 | Univ Utrecht | Mutant protein and refolding method |
JP2006506467A (ja) | 2002-08-02 | 2006-02-23 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
SI2351579T1 (sl) | 2002-10-11 | 2017-05-31 | Glaxosmithkline Biologicals Sa | Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
EP1943269A2 (en) * | 2005-10-14 | 2008-07-16 | Intercell AG | Neisseria meningitidis antigens |
WO2007144316A2 (en) | 2006-06-12 | 2007-12-21 | Glaxosmithkline Biologicals Sa | Vaccine |
AU2009329193A1 (en) | 2008-12-17 | 2011-07-14 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
EP2411048B1 (en) | 2009-03-24 | 2020-05-06 | GlaxoSmithKline Biologicals SA | Adjuvanting meningococcal factor h binding protein |
RU2555757C2 (ru) | 2009-03-24 | 2015-07-10 | Новартис Аг | Комбинации менингококкового фактор н-связывающего белка и пневмококковых сахаридных конъюгатов |
AU2010288239B2 (en) | 2009-08-27 | 2014-01-16 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
EP2470204B1 (en) | 2009-08-27 | 2015-12-16 | GlaxoSmithKline Biologicals SA | Hybrid polypeptides including meningococcal fhbp sequences |
WO2011039631A2 (en) | 2009-09-30 | 2011-04-07 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
BR112012010531A2 (pt) | 2009-10-27 | 2019-09-24 | Novartis Ag | "polipeptídeos de modificação meningocócica fhbp" |
JP2013521770A (ja) | 2010-03-10 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
CN103124737A (zh) | 2010-03-11 | 2013-05-29 | 葛兰素史密丝克莱恩生物有限公司 | 针对革兰氏阴性菌例如奈瑟菌属感染或疾病的免疫原性组合物或疫苗 |
CA2793510A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
JP2013541322A (ja) * | 2010-07-30 | 2013-11-14 | グリフィス・ユニバーシティ | 組換え髄膜炎菌(ナイセリア・メニンギティディス)PorAポーリンタンパク質 |
BR112013005626B1 (pt) | 2010-09-10 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
WO2012054879A1 (en) * | 2010-10-22 | 2012-04-26 | Duke University | Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
BR112014016223A8 (pt) | 2011-12-29 | 2017-07-04 | Novartis Ag | combinações adjuvantes de proteínas de ligação de fator h meningocócico |
ES2654613T3 (es) | 2012-02-02 | 2018-02-14 | Glaxosmithkline Biologicals Sa | Promotores para una expresión aumentada de proteínas en meningococos |
EP2823312B1 (en) | 2012-03-08 | 2019-08-07 | GlaxoSmithKline Biologicals SA | In vitro potency assay for protein-based meningococcal vaccines |
NZ630133A (en) | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
AU2013311702A1 (en) | 2012-09-06 | 2015-02-19 | Novartis Ag | Combination vaccines with serogroup B meningococcus and D/T/P |
HUE052293T2 (hu) | 2014-02-28 | 2021-04-28 | Glaxosmithkline Biologicals Sa | Módosított fHbp meningococcus-polipeptidek |
PT3544637T (pt) | 2016-11-25 | 2021-02-03 | Glaxosmithkline Biologicals Sa | Conjugados omv-antigénio nativos e sua utilização |
WO2018096007A2 (en) | 2016-11-25 | 2018-05-31 | Glaxosmithkline Biologicals S.A. | Immunogenic conjugates and use thereof |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4843000A (en) | 1979-12-26 | 1989-06-27 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
US4849338A (en) | 1982-07-16 | 1989-07-18 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
US4550081A (en) | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
EP0273116A3 (en) * | 1986-10-09 | 1990-05-02 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Gonococcal and meningococcal polypeptides, vaccines and diagnostics |
US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US5785973A (en) | 1988-02-01 | 1998-07-28 | Praxis Biologics, Inc. | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
WO1989009385A1 (fr) | 1988-03-24 | 1989-10-05 | Zach, Johann | Dispositif manometrique ou dynamometrique |
EP0449958B9 (en) * | 1988-12-19 | 2003-05-28 | American Cyanamid Company | Meningococcal class 1 outer-membrane protein vaccine |
WO1992001813A1 (en) | 1990-07-25 | 1992-02-06 | Syngene, Inc. | Circular extension for generating multiple nucleic acid complements |
US5422252A (en) | 1993-06-04 | 1995-06-06 | Becton, Dickinson And Company | Simultaneous amplification of multiple targets |
US5646259A (en) | 1995-03-24 | 1997-07-08 | St. Louis University | DNA encoding haemophilus adhesion proteins |
US6143495A (en) | 1995-11-21 | 2000-11-07 | Yale University | Unimolecular segment amplification and sequencing |
GB9611673D0 (en) * | 1996-06-05 | 1996-08-07 | Peptide Therapeutics Ltd | Meningococcal vaccine |
AU9363798A (en) | 1997-11-06 | 1999-05-31 | Chiron S.P.A. | Neisserial antigens |
GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
SG152917A1 (en) * | 1998-01-14 | 2009-06-29 | Chiron Srl | Neisseria meningitidis antigens |
EP2261347A3 (en) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
GB9810276D0 (en) | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
WO2000061165A1 (en) | 1999-04-13 | 2000-10-19 | Smithkline Beecham Corporation | Conserved adhesin motif and methods of use thereof |
NZ581940A (en) * | 1999-04-30 | 2011-07-29 | Novartis Vaccines & Diagnostic | Conserved neisserial antigens |
AU780308B2 (en) * | 1999-04-30 | 2005-03-17 | J. Craig Venter Institute, Inc. | Neisseria genomic sequences and methods of their use |
GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
NZ520445A (en) | 2000-01-25 | 2004-02-27 | Univ Queensland | Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA |
JP2006506467A (ja) * | 2002-08-02 | 2006-02-23 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
CA2550927A1 (en) * | 2003-12-23 | 2005-07-14 | Glaxosmithkline Biologicals S.A. | A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
-
2001
- 2001-01-25 NZ NZ520445A patent/NZ520445A/en not_active IP Right Cessation
- 2001-01-25 BR BR0107857-7A patent/BR0107857A/pt active Search and Examination
- 2001-01-25 PL PL356819A patent/PL216780B1/pl not_active IP Right Cessation
- 2001-01-25 US US09/771,382 patent/US7947291B2/en not_active Expired - Fee Related
- 2001-01-25 CN CN2011102811093A patent/CN102417537A/zh active Pending
- 2001-01-25 CA CA002398139A patent/CA2398139A1/en not_active Abandoned
- 2001-01-25 MX MXPA02007184A patent/MXPA02007184A/es active IP Right Grant
- 2001-01-25 ES ES01946868T patent/ES2389719T3/es not_active Expired - Lifetime
- 2001-01-25 CN CN01807183A patent/CN1419564A/zh active Pending
- 2001-01-25 IL IL15082201A patent/IL150822A0/xx unknown
- 2001-01-25 JP JP2001561034A patent/JP2003523208A/ja active Pending
- 2001-01-25 EP EP01946868A patent/EP1252182B1/en not_active Expired - Lifetime
- 2001-01-25 CZ CZ2002-2482A patent/CZ304379B6/cs not_active IP Right Cessation
- 2001-01-25 KR KR1020027009512A patent/KR100698561B1/ko not_active IP Right Cessation
- 2001-01-25 HU HU0300696A patent/HUP0300696A3/hu unknown
- 2001-01-25 AU AU28181/01A patent/AU2818101A/en not_active Abandoned
- 2001-01-25 EP EP10184045A patent/EP2395013A3/en not_active Withdrawn
- 2001-01-25 WO PCT/AU2001/000069 patent/WO2001055182A1/en active IP Right Grant
-
2002
- 2002-07-18 IL IL150822A patent/IL150822A/en not_active IP Right Cessation
- 2002-07-22 NO NO20023487A patent/NO332229B1/no not_active IP Right Cessation
- 2002-08-01 ZA ZA200206153A patent/ZA200206153B/xx unknown
-
2007
- 2007-10-31 US US11/933,245 patent/US8367070B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/933,411 patent/US8383790B2/en not_active Expired - Fee Related
-
2011
- 2011-09-30 JP JP2011218296A patent/JP2012051902A/ja active Pending
-
2013
- 2013-02-01 US US13/757,124 patent/US20130136762A1/en not_active Abandoned
- 2013-09-11 JP JP2013188798A patent/JP2014024849A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300696A3 (en) | Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha | |
IL136684A0 (en) | Novel surface protein of neisseria meningitidis | |
IL151942A0 (en) | Compositions and methods for enhancing immunogenicity of antigens | |
CY2013025I1 (el) | Ετερολογος εκφραση των πρωτεϊνων της neisseria | |
HUP0204250A3 (en) | Use of hiv-protein or -polynucleotide for vaccine produce | |
CY2011001I1 (el) | Εμβολια συνδυασμου για neisseria meningitidis | |
IL159894A0 (en) | Therapeutic agents comprising pro-apoptotic proteins | |
IL212419A0 (en) | Methods of administering anti-tnf antibodies | |
HK1041541A1 (zh) | 鑑別使用人的靈活方法 | |
TW479494U (en) | Structure of pillow | |
IL151355A0 (en) | Vaccine for the treatment of artherosclerosis | |
IL154301A0 (en) | Purification of hbv antigens for use in vaccines | |
HK1064024A1 (en) | Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein | |
PL367329A1 (pl) | Sposoby obniżania immunogeniczności polipeptydów | |
FR2809615B3 (fr) | Appareil electromecanique pour assurer le mouvement de flexion/extension des membres inferieurs chez les patients presentant une diminution des fonctions superieures | |
AU2001267613A1 (en) | Adjuvant composition comprising FHA protein or fragment of FHA protein in free form | |
EP1452597A4 (en) | PROTEIN ACTIVATION METHOD | |
TW567810U (en) | Massage pillow | |
TW492296U (en) | Multifunctional pillow for children | |
GB0031218D0 (en) | Metgod of vaccine preparation | |
TW457913U (en) | Construction of disposable pulp-molded pillow | |
TW435704U (en) | Structure improvement of glasses foot for eyeglasses | |
GB0005728D0 (en) | Conserved antigens | |
AUPR275901A0 (en) | Improvements in design of pillows | |
TW503713U (en) | Improved structure of slippers for using in bathroom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20140125 |